NEUP/ 10/20/2025 · 5:15 PM Neuphoria's Social Anxiety Treatment Fails Phase 3 Trial Neuphoria's AFFIRM-1 Phase 3 trial for BNC210 social anxiety treatment misses all endpoints. Company halts SAD program, reviews options.
